NicOx's NDA for osteoarthritis drug accepted for filing by FDA

Posted on: Thu, 19 Nov 2009 09:52:00 EST

Symbols: NICXF

Nov 19, 2009 (Datamonitor via COMTEX) --
NICXF | Quote | Chart | News | PowerRating -- NicOx, a French biopharmaceutical company, has received a filing communication from the FDA stating that the new drug application, or NDA, for naproxcinod is accepted for filing. The company has submitted the NDA on September 24, 2009, seeking approval for the relief of the signs and symptoms of osteoarthritis.

Based on the Prescription Drug User Fee Act, the FDA will complete its review 10 months after submission and has set an action date of July 24, 2010.

The naproxcinod NDA file is supported by data from a large program of 34 clinical trials that involved more than 4,000 subjects. The program evaluated the efficacy of naproxcinod in relieving signs and symptoms of osteoarthritis, as well as its safety. During its safety evaluation, particular care was given to its effect on blood pressure.

NicOx plans to submit a marketing authorization application for naproxcinod to the European Medicines Agency by the end of 2009.

Philippe Serrano, vice president of regulatory affairs at NicOx, said: "We are very pleased to receive this filing communication from the FDA and it is thanks to a collective effort by our entire R&D department, which has provided a high-quality application. We believe that when approved, naproxcinod could represent a valuable new treatment option for osteoarthritis patients."

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

For full details on (NICXF) NICXF. (NICXF) has Short Term PowerRatings at TradingMarkets. Details on (NICXF) Short Term PowerRatings is available at This Link.

How to Successfully Trade ETFs

Do you want to learn how to trade more successfully, more consistently... and with more confidence?

If so, then the TPS strategy is for you.

Hundreds, if not now thousands, of ETF traders successfully use the TPS trading strategy to find the best ETF trade set-ups each day to place winning trades.

What stocks and ETFs are headed up and down this week?.

The TradingMarkets Weekly Newsletter covers this in depth and gives performance information on the previous week.

UPCOMING EVENTS

Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.

Thursday September 16 12:30 PM

Hear What Kevin Haggerty Sees in the Stock Market Today!

Wednesday September 8 01:30 PM

Building High Performing Portfolios with The Machine

Tuesday September 7 04:30 PM

TradingMarkets' Swing Trading College Fall 2010 Presentation

* Attendance is strictly limited and are filled on a first-come, first-served basis.

1.	Buying Weakness and Selling Strength
2.	5 Ways to Handle The Quicksand Of Trading
3.	2 Indicators to Help You Find Market Bottoms
4.	5 Principles of Leadership and Trading
5.	How to Gain Confidence, Commitment, Courage, and Control
6.	10 Steps to Successful Day Trading, Part 1
7.	Aim for Excellence, Not Perfection in Trading
8.	4 Ways to Think Like a Winning Trader
9.	My Favorite Exit
10.	A Basic Rule for Limiting Risk

Name	Symbol	PR
Direxion Developed Markets Bear 3X Shares	DPK	10
ProShares UltraShort MSCI EAFE	EFU	10
ProShares Trust II: UltraShort Euro	EUO	10
Direxion Financial Bear 3x Shares	FAZ	10
Rydex Invrs 2x S&P Sel Sctr Finl ETF	RFN	10
ProShares UltraShort Russell 1000 Value	SJF	10
ProShares UltraShort Financials	SKF	10
PowerShares Build America Bond	BAB	9
Direxion Large Cap Bear 3x Shares	BGZ	9
Vanguard Intermediate Term Bond ETF	BIV	9

About TradingMarkets Advertise Contact Careers Link to Us Help Terms & Conditions Privacy Policy Return Policy Testimonials Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.